Precision for Medicine
PrivateLast Round
Private Equity
Nov 20, 2020
Est. Valuation
$2.35B
Total Funding Raised
$500M
Company Overview
Precision for Medicine is a clinical research organization that provides laboratory services, clinical trial management, and data intelligence for the life sciences industry.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Biotechnology, Precision Medicine, Drug Discovery, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Precision for Medicine Comparables
Compare Precision for Medicine with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Novotech Health Holdings | 83% | |
| Syneos Health | 82% | |
| CTI Clinical Trial and Consulting Services | 81% |
Precision for Medicine Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Equity | Nov 20, 2020 | ||||
| Private Equity | Dec 19, 2017 | ||||
| Private Equity | Dec 22, 2015 | ||||
| Private Equity | Apr 2, 2013 |
Precision for Medicine Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Blackstone | Private Equity |
| J.H. Whitney & Co | Private Equity |
| Oak HC/FT | Private Equity |
| Vida Ventures | Private Equity |
| TPG Growth | Private Equity |
| Oak Investment Partners | Private Equity |
| J.H. Whitney Capital Partners | Private Equity |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 14, 2024
Grew 17% QoQ, from 1,279 to 1,501 employees.
- Nov 20, 2020
Raised $2.35B led by Blackstone.
Precision for Medicine Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Precision for Medicine's valuation, stock price, and market status.
Is Precision for Medicine a public or private company?
Precision for Medicine is a private company.
What is the current stock price of Precision for Medicine?
Precision for Medicine is a private company with no public stock price. Caplight tracks Precision for Medicine's secondary market activity and provides MarketPrice estimates to Caplight users.
How much is Precision for Medicine worth (valuation)?
Precision for Medicine's valuation is estimated at $2.4B based on funding round data.
Can I buy Precision for Medicine stock?
Precision for Medicine shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Precision for Medicine's last funding round?
Precision for Medicine's most recent funding round was Private Equity on November 20, 2020.
Who are the main investors in Precision for Medicine?
Key investors in Precision for Medicine include Blackstone, J.H. Whitney & Co, TPG Growth, Oak Investment Partners, Berkshire Partners.
Will Precision for Medicine IPO soon?
No public IPO plans have been announced for Precision for Medicine.
How can I track Precision for Medicine secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Precision for Medicine's secondary market activity and sign up for updates.